Company intelligence / Profile preview

Partners Innovation Fund

Boston, Massachusetts, United States

Ownership: Private
Employees: ~9
Development stage: Other

Overview

The Partners Innovation Fund is a venture capital fund that invests in life science companies, particularly those emerging from Mass General Brigham. It supports the development of innovative technologies and therapies, having launched 43 companies since its inception.

Therapeutic areas: OncologyNeurologyRare Diseases
Modalities: AntibodiesGene therapyCAR–T cellsTherapeutic oligonucleotidesSmall molecules
Industry: Investors

Partnerships

Collaborations with pharmaceutical companiesStrategic partnerships with venture firms like Atlas Venture, Baxalta Ventures, and SR One

Beyond the preview

Go deeper on Partners Innovation Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Partners Innovation Fund.

Explore the full profile